Go 
Volumes : Issues : Articles
Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
·CW January 2009
·CW February 2009
·CW March 2009
·CW April 2009
·CW May 2009
·CW June 2009


CW June 2009

 Volume 18
Issue Number 6
June 2009
ISSN 1059380
News in Brief
Cancer Incidence Could Rise Sharply in Coming Decades
HPV Status and Progression of Oral Cancer
Encouraging Activity for Ixabepilone/Bevacizumab in Metastatic Breast Cancer
Nab-Paclitaxel Tops Docetaxel for First- Line Treatment of Metastatic Breast Cancer
Sandostatin LAR Controls Tumor Growth in Metastatic Neuroendocrine Midgut Tumors
Cisplatin/S-1 Is an Optimum Substitute for Cisplatin/5-FU in Advanced Gastric Cancer
Induction Therapy with Bortezomib Plus Chemotherapy Overcomes Poor Cytogenetics in Young Multiple Myeloma Patients
Combination of Four Drugs Proves Highly Active in Newly Diagnosed Multiple Myeloma
Combination of Panobinostat and Lenalidomide/Dexamethasone Active in Relapsed/Refractory Multiple Myeloma
In CML-CP, Dasatinib Once-Daily Offers Best Profile
Three Drug Combination Shows Activity in High-Risk, Relapsed/Refractory Follicular Lymphoma
Afinitor Shrinks Tumors in Many Types of Lymphoma
Ipilimumab: Long-Term Survival Benefit in 30% with Advanced Melanoma
Ipilimumab in Advanced Melanoma
Tumor and Bone Activity with Dasatinib and Docetaxel in Castrate-Resistant Prostate Cancer
Dasatinib in Metastatic Castrate-Resistant Prostate Cancer
Download Complete Issue CW June 2009

Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.


Mountain Media ecommerce solutions Ecommerce Solutions by Mountain Media  

Re-initialize IP-based Login